Literature DB >> 24318419

Increased ALK1 copy number and renal cell carcinoma-a case report.

Ciara Ryan1, Nick Mayer, Joan Cunningham, Gordon Hislop, Norman Pratt, Stewart Fleming.   

Abstract

There have been recent reports of a rare variant of renal cell carcinoma associated with upregulation of the anaplastic lymphoma kinase gene (ALK) arising as a consequence of chromosomal translocations. The tumours were described as having a characteristic morphology. Here, we describe a case with similar morphology characterised by eosinophilic cells, abundant intracytoplasmic lumina and scattered large ganglion-like tumour cells. There was focal staining for ALK demonstrated by immunohistochemistry. However, rather than exhibiting a chromosomal translocation involving ALK, the use of FISH and a break-apart probe demonstrated that there was increased copy number of intact 2p23, the chromosomal region containing the ALK gene. Furthermore, the use of comparative genomic hybridisation showed increase of the whole of chromosome 2 along with chromosomes 6 and 17. There was no evidence of loss of 3p nor of trisomy of 7 associated with clear cell and papillary carcinoma, respectively. We suggest that this demonstrates a novel mechanism of upregulation of ALK activity by increased copy number occurring during the development of a renal carcinoma with the characteristic ALK-associated morphology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24318419     DOI: 10.1007/s00428-013-1520-3

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  A tumour promoter induces alterations in vinculin and actin distribution in human renal epithelium.

Authors:  M A Rahilly; S Fleming
Journal:  J Pathol       Date:  1992-03       Impact factor: 7.996

2.  Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.

Authors:  Larisa V Debelenko; Susana C Raimondi; Najat Daw; Bangalore R Shivakumar; Dali Huang; Marilu Nelson; Julia A Bridge
Journal:  Mod Pathol       Date:  2010-11-12       Impact factor: 7.842

3.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.

Authors:  John R Srigley; Brett Delahunt; John N Eble; Lars Egevad; Jonathan I Epstein; David Grignon; Ondrej Hes; Holger Moch; Rodolfo Montironi; Satish K Tickoo; Ming Zhou; Pedram Argani
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

Review 4.  ALKoma: a cancer subtype with a shared target.

Authors:  Hiroyuki Mano
Journal:  Cancer Discov       Date:  2012-05-21       Impact factor: 39.397

5.  Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors.

Authors:  Ozkan Bagci; Sait Tumer; Nur Olgun; Oguz Altungoz
Journal:  Cancer Lett       Date:  2011-11-13       Impact factor: 8.679

6.  ALK rearrangement in sickle cell trait-associated renal medullary carcinoma.

Authors:  Adrián Mariño-Enríquez; Wen-Bin Ou; Christopher B Weldon; Jonathan A Fletcher; Antonio R Pérez-Atayde
Journal:  Genes Chromosomes Cancer       Date:  2010-12-13       Impact factor: 5.006

7.  Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method.

Authors:  Emiko Sugawara; Yuki Togashi; Naoto Kuroda; Seiji Sakata; Satoko Hatano; Reimi Asaka; Takeshi Yuasa; Junji Yonese; Masanobu Kitagawa; Hiroyuki Mano; Yuichi Ishikawa; Kengo Takeuchi
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

8.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

9.  Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers.

Authors:  Eva Lin; Li Li; Yinghui Guan; Robert Soriano; Celina Sanchez Rivers; Sankar Mohan; Ajay Pandita; Jerry Tang; Zora Modrusan
Journal:  Mol Cancer Res       Date:  2009-09-08       Impact factor: 5.852

10.  Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer.

Authors:  Hong Ren; Zhi-Ping Tan; Xin Zhu; Katherine Crosby; Herbert Haack; Jian-Min Ren; Sean Beausoleil; Albrecht Moritz; Gregory Innocenti; John Rush; Yi Zhang; Xin-Min Zhou; Ting-Lei Gu; Yi-Feng Yang; Michael J Comb
Journal:  Cancer Res       Date:  2012-05-08       Impact factor: 12.701

View more
  4 in total

1.  Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Sean R Williamson; Anthony J Gill; Ondrej Hes; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-02-01       Impact factor: 7.842

Review 2.  Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review.

Authors:  Giovanni Maria Iannantuono; Silvia Riondino; Stefano Sganga; Mario Roselli; Francesco Torino
Journal:  Int J Mol Sci       Date:  2022-04-03       Impact factor: 5.923

3.  ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.

Authors:  Naoto Kuroda; Kiril Trpkov; Yuan Gao; Maria Tretiakova; Yajuan J Liu; Monika Ulamec; Kengo Takeuchi; Abbas Agaimy; Christopher Przybycin; Cristina Magi-Galluzzi; Soichiro Fushimi; Fumiyoshi Kojima; Malthide Sibony; Jen-Fan Hang; Chin-Chen Pan; Asli Yilmaz; Farshid Siadat; Emiko Sugawara; Pierre-Alexandre Just; Nikola Ptakova; Ondrej Hes
Journal:  Mod Pathol       Date:  2020-05-28       Impact factor: 7.842

Review 4.  ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review.

Authors:  Jing Yang; Lei Dong; Hong Du; Xiu-Bo Li; Yan-Xiao Liang; Guo-Rong Liu
Journal:  Diagn Pathol       Date:  2019-10-18       Impact factor: 2.644

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.